ZFIN ID: ZDB-PERS-150505-2
Patten, Shumoogum
Email: kessenp@gmail.com
URL:
Affiliation:
Address:
Country:
Phone:
Fax:
ORCID ID:


BIOGRAPHY AND RESEARCH INTERESTS


PUBLICATIONS
Fortier, G., Butti, Z., Patten, S.A. (2020) Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish. Biomedicines. 8(10):
Rabanel, J.M., Piec, P.A., Landri, S., Patten, S.A., Ramassamy, C. (2020) Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability. Journal of controlled release : official journal of the Controlled Release Society. 328:679-695
Breuer, M., Patten, S.A. (2020) A Great Catch for Investigating Inborn Errors of Metabolism-Insights Obtained from Zebrafish. Biomolecules. 10(9):
Golbaghi, G., Pitard, I., Lucas, M., Haghdoost, M.M., de Los Santos, Y.L., Doucet, N., Patten, S.A., Sanderson, J.T., Castonguay, A. (2020) Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos. European Journal of Medicinal Chemistry. 188:112030
Jamadagni, P., Patten, S.A. (2019) 25-hydroxycholesterol impairs neuronal and muscular development in zebrafish. Neurotoxicology. 75:14-23
Haghdoost, M.M., Golbaghi, G., Guard, J., Sielanczyk, S., Patten, S.A., Castonguay, A. (2019) Synthesis, characterization and biological evaluation of cationic organoruthenium(ii) fluorene complexes: influence of the nature of the counteranion. Dalton transactions (Cambridge, England : 2003). 48(35):13396-13405
de Molliens, M.P., Jamadagni, P., Létourneau, M., Devost, D., Hébert, T.E., Patten, S.A., Fournier, A., Chatenet, D. (2019) Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor. Biochimica et biophysica acta. General subjects. 1863(11):129398
Golbaghi, G., Haghdoost, M.M., Yancu, D., Santos, Y.L.L., Doucet, N., Patten, S.A., Sanderson, J.T., Castonguay, A. (2019) Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos. Organometallics. 38:702-711
Patten, S.A., Aggad, D., Martinez, J., Tremblay, E., Petrillo, J., Armstrong, G.A., La Fontaine, A., Maios, C., Liao, M., Ciura, S., Wen, X.Y., Rafuse, V., Ichida, J., Zinman, L., Julien, J.P., Kabashi, E., Robitaille, R., Korngut, L., Parker, J.A., Drapeau, P. (2017) Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI insight. 2(22)
Haghdoost, M., Golbaghi, G., Létourneau, M., Patten, S.A., Castonguay, A. (2017) Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin. European Journal of Medicinal Chemistry. 132:282-293
Patten, S.A., Roy, B., Cunningham, M.E., Stafford, J.L., and Ali, D.W. (2010) Protein kinase Cgamma is a signaling molecule required for the developmental speeding of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor kinetics. The European journal of neuroscience. 31(9):1561-1573

NON-ZEBRAFISH PUBLICATIONS